Detalhe da pesquisa
1.
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a 6 months follow-up study: The CoVaDiab study I.
Diabetes Metab Res Rev
; 39(3): e3601, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533777
2.
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes.
Diabetes Metab Res Rev
; 39(5): e3632, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36880127
3.
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study.
Diabetes Obes Metab
; 23(7): 1624-1630, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33764666
4.
Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study.
Diabetes Obes Metab
; 25(11): 3415-3419, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014612
5.
Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes.
Diabetes Res Clin Pract
; 179: 109022, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34450248
6.
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I).
Diabetes Res Clin Pract
; 169: 108454, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32971157
7.
Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy.
Diabetes Care
; 43(8): e86-e87, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32503838